Medexus Pharmaceuticals Inc. (TSX:MDP)
Canada · Delayed Price · Currency is CAD 5.12
+0.20 (4.07%)
Nov 6, 2026, 4:00 PM EST
Medexus Pharmaceuticals Market Cap
Medexus Pharmaceuticals has a market cap or net worth of CAD 160.9 million as of November 6, 2026. It is the 23,974th most valuable company in the world and the 628th biggest in Canada. Its market cap has increased by 85.19% in one year.
Market Cap
160.90M
Enterprise Value
190.60M
Revenue
146.70M
Global Rank
Country Rank
#628 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since December 27, 2013, Medexus Pharmaceuticals's market cap has increased from 32.21M to 160.90M, an increase of 399.59%. That is a compound annual growth rate of 13.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 160.90M | 70.38% |
| Dec 31, 2025 | 94.44M | 10.49% |
| Dec 31, 2024 | 85.47M | 41.48% |
| Dec 29, 2023 | 60.41M | 45.19% |
| Dec 30, 2022 | 41.61M | -17.74% |
| Dec 31, 2021 | 50.58M | -48.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cresco Labs | 307.90M |
| TerrAscend | 222.61M |
| Cannara Biotech | 202.37M |
| BioSyent | 193.95M |
| Organigram Global | 188.95M |
| Cardiol Therapeutics | 168.22M |
| HLS Therapeutics | 129.38M |
| Grown Rogue International | 127.47M |